Cross Roads Extremity

Memphis, United States Founded: 2014 • Age: 12 yrs Acquired By DePuy Synthes
Orthopaedic devices for complex foot and ankle conditions are developed.

About Cross Roads Extremity

Cross Roads Extremity is a company based in Memphis (United States) founded in 2014 by Chad Hollis was acquired by DePuy Synthes in February 2022.. Cross Roads Extremity has raised $5.44 million across 5 funding rounds from investors including Runway Growth Capital, DePuy Synthes and HealthpointCapital. Cross Roads Extremity offers products and services including DynaForce Staple Compression Plates, MINIBunion, DynaBunion, and Keel-Lock Plate. Cross Roads Extremity operates in a competitive market with competitors including Treace Medical Concepts, Bioretec, Loci Orthopaedics, IlluminOss Medical and Stanmore Implants, among others.

  • Headquarter Memphis, United States
  • Founders Chad Hollis
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $5.44 M (USD)

    in 5 rounds

  • Latest Funding Round
    $15 M (USD), Debt – Venture

    Jul 14, 2021

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    DePuy Synthes

    & 1 more

    (Feb 10, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cross Roads Extremity

Cross Roads Extremity offers a comprehensive portfolio of products and services, including DynaForce Staple Compression Plates, MINIBunion, DynaBunion, and Keel-Lock Plate. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides compression for foot surgery staples to enhance healing.

Offers minimally invasive solutions for bunion correction procedures.

Delivers advanced 4D technology for effective bunion treatment.

Ensures stability in foot fusions with staple integration.

People of Cross Roads Extremity
Headcount 50-200
Employee Profiles 6
Board Members and Advisors 3
Employee Profiles
People
Angie Marik
Quality Manager
People
Chad Hollis
VP, R&D & Co-Founder
People
Vernon Hartdegen
CEO, Co-Founder & Board Member
People
Alex Winber
VP, Marketing

Unlock access to complete

Board Members and Advisors
people
John H. Foster
Board Member
people
Gary Stevenson
Board Member
people
Milen Todorov
Board Member

Unlock access to complete

Funding Insights of Cross Roads Extremity

Cross Roads Extremity has successfully raised a total of $5.44M across 5 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $15 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Debt – Venture — $15.0M
  • First Round

    (13 Aug 2014)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Debt – Venture - Cross Roads Extremity Valuation

investors

Jan, 2018 Amount Series A - Cross Roads Extremity Valuation

investors

Jun, 2016 Amount Seed - Cross Roads Extremity Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cross Roads Extremity

Cross Roads Extremity has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Runway Growth Capital, DePuy Synthes and HealthpointCapital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture debt financing is provided to companies across multiple sectors.
Founded Year Domain Location
HealthpointCapital is focused on private equity in musculoskeletal healthcare.
Founded Year Domain Location
Orthopedic and neurosurgery products are developed and marketed worldwide.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cross Roads Extremity

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cross Roads Extremity

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cross Roads Extremity Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cross Roads Extremity

Cross Roads Extremity operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Treace Medical Concepts, Bioretec, Loci Orthopaedics, IlluminOss Medical and Stanmore Implants, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Orthopedic foot and ankle correction systems are developed and offered.
domain founded_year HQ Location
Provider of bioabsorbable, bioactive and drug-releasing surgical implants
domain founded_year HQ Location
Thumb implant for thumb base arthritis
domain founded_year HQ Location
Minimally invasive orthopedic systems for bone fracture stabilization are developed.
domain founded_year HQ Location
Modular implants for limb sparing and complex primary and revision joint replacement
domain founded_year HQ Location
Metal implants for orthopedic fracture fixation are developed and marketed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cross Roads Extremity

Frequently Asked Questions about Cross Roads Extremity

When was Cross Roads Extremity founded?

Cross Roads Extremity was founded in 2014.

Where is Cross Roads Extremity located?

Cross Roads Extremity is headquartered in Memphis, United States. It is registered at Memphis, Tennessee, United States.

Is Cross Roads Extremity a funded company?

Cross Roads Extremity is a funded company, having raised a total of $5.44M across 5 funding rounds to date. The company's 1st funding round was a Seed of $411K, raised on Aug 13, 2014.

What does Cross Roads Extremity do?

CrossRoads Extremity was established in 2014 in Memphis, United States, within the orthopaedics sector. Products are created for surgeons addressing complex foot and ankle issues. The lineup features CrossTIE as a pre-assembled, sterile PIP arthrodesis instrument and implant; MotoCLIP as a Nitinol-based elastic fixation with insertion system; pre-shaped allograft wedges; moldable DBM putty for fixation; and titanium screws in headed, headless, and snap-off varieties for precise securement.

Who are the top competitors of Cross Roads Extremity?

Cross Roads Extremity's top competitors include Treace Medical Concepts, Loci Orthopaedics and Bioretec.

What products or services does Cross Roads Extremity offer?

Cross Roads Extremity offers DynaForce Staple Compression Plates, MINIBunion, DynaBunion, and Keel-Lock Plate.

Who are Cross Roads Extremity's investors?

Cross Roads Extremity has 3 investors. Key investors include Runway Growth Capital, DePuy Synthes, and HealthpointCapital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available